That morning, Vera announced that its biologics license application (BLA) for its atacicept was accepted for priority review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback